Metraipolis › archive › dc_228d799ae43f

Long-term benefit from high-dose ifosfamide in sarcoma depends on sustained prior control and timely intervention: a machine learning analysis — Europe PMC PMID:41504936

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41504936
DOI
10.1007/s00432-[numero omesso]-8
License (as archived)
solo-consultazione
Archived
2026-11-06T23:31:49.913Z
SHA-256 of the archived text
97b3769ee01a0dd96195f979bcecd250bbb1d27238758269ccb2afc8a0417356
Stable URL of this page
https://metraipolis.com/documento/dc_228d799ae43f

How to cite

Long-term benefit from high-dose ifosfamide in sarcoma depends on sustained prior control and timely intervention: a machine learning analysis — Europe PMC PMID:41504936 — Europe PMC (en), https://europepmc.org/article/MED/41504936 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_228d799ae43f (Metraipolis archive dc_228d799ae43f, sha256 97b3769ee01a0dd96195f979bcecd250bbb1d27238758269ccb2afc8a0417356)
BibTeX
@misc{dc228d799ae43f,
  title = {Long-term benefit from high-dose ifosfamide in sarcoma depends on sustained prior control and timely intervention: a machine learning analysis — Europe PMC PMID:41504936},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41504936},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_228d799ae43f; sha256 97b3769ee01a0dd96195f979bcecd250bbb1d27238758269ccb2afc8a0417356},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41504936. Agents can read the archived copy with the MCP tool read_document.